PuraPharm moves to modernise Articles of Association with electronic meeting and voting powers

PuraPharm Corp. Ltd. ( (HK:1498) ) has provided an announcement.

PuraPharm Corporation Limited plans to amend its Articles of Association to align with the latest legal and regulatory requirements of the Hong Kong Stock Exchange, including changes to Appendix A1 of the Listing Rules effective 1 July 2025. The amendments, which require shareholder approval by special resolution at the annual general meeting scheduled for 27 May 2026, aim to modernise corporate governance by enabling electronic and hybrid general meetings, permitting electronic voting and instructions from shareholders, and streamlining the electronic dissemination of corporate documents, signalling a shift toward more flexible and technology-driven shareholder engagement.

The company proposes to expressly allow shareholders to vote via electronic means, facilitate fully electronic and hybrid general meetings, remove certain notice requirements tied to website publication, and make related housekeeping updates to its governing documents. A circular detailing the proposed changes and the AGM notice will be sent to shareholders in due course, with the package of measures expected to enhance compliance, reduce administrative friction and support more efficient communication between the company and its investors.

More about PuraPharm Corp. Ltd.

PuraPharm Corporation Limited is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange under stock code 1498. The group operates in the healthcare and pharmaceutical space, with its shares held by a mix of executive, non-executive and independent non-executive directors representing its governance structure.

Average Trading Volume: 229,365

Technical Sentiment Signal: Sell

Current Market Cap: HK$160.5M

Find detailed analytics on 1498 stock on TipRanks’ Stock Analysis page.